Corrigendum to "Inborn errors of IL-12/23- and IFN-γ-mediated immunity: Molecular, cellular, and clinical features" [Semin. Immunol. 18 (2006) 347-361] (DOI:10.1016/j.smim.2006.07.010);Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features

Seminars in Immunology

Volumn 18, Issue 6, 2006, Pages 347-361

  Filipe Santos, Orchidée ^a   Bustamante, Jacinta ^a   Chapgier, Ariane ^a   Vogt, Guillaume ^a   de Beaucoudrey, Ludovic ^a   Feinberg, Jacqueline ^a   Jouanguy, Emmanuelle ^a   Boisson Dupuis, Stéphanie ^a   Fieschi, Claire ^a,b   Picard, Capucine ^a,c   Casanova, Jean Laurent ^a,c  

^a IMAGINE INSTITUTE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

IFN ; IL 12; IL 23; Mycobacterium; Primary immunodeficiency; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; GAMMA INTERFERON; I KAPPA B KINASE GAMMA; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; LEUCINE ZIPPER PROTEIN; STAT1 PROTEIN;

ABSENCE OF SIDE EFFECTS; ALLELE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE PREDISPOSITION; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE; MYCOBACTERIUM; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DOMAIN; REVIEW; TUBERCULOSIS; X CHROMOSOME LINKED DISORDER;

EID: 33749600724     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.02.002     Document Type: Erratum

References (147)

1. Hamosh A., Scott A.F., Amberger J.S., Bocchini C.A., and McKusick V.A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucl Acids Res 33 (2005) D514-D517
2. Mimouni J. Our experiences in three years of BCG vaccination at the center of the O.P.H.S. at Constantine; study of observed cases (25 cases of complications from BCG vaccination). Alger Med 55 (1951) 1138-1147
3. Levin M., Newport M.J., D'Souza S., Kalabalikis P., Brown I.N., Lenicker H.M., et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?. Lancet 345 (1995) 79-83
4. Casanova J.L., Jouanguy E., Lamhamedi S., Blanche S., and Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 346 (1995) 581
5. Casanova J.L., Blanche S., Emile J.F., Jouanguy E., Lamhamedi S., Altare F., et al. Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics 98 (1996) 774-778
6. Dorman S.E., and Holland S.M. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 11 (2000) 321-333
7. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20 (2002) 581-620
8. Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondaneche M.C., Tuerlinckx D., Blanche S., et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 100 (1997) 2658-2664
9. Altare F., Ensser A., Breiman A., Reichenbach J., Baghdadi J.E., Fischer A., et al. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis 184 (2001) 231-236
10. Caragol I., Raspall M., Fieschi C., Feinberg J., Larrosa M.N., Hernandez M., et al. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis 37 (2003) 302-306
11. Özbek N., Fieschi C., Yilmaz B.T., De Beaucoudrey L., Bikmaz Y.E., and Casanova J.L. Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis. Clin Infect Dis 40 (2005) 55-58
12. Alcais A., Fieschi C., Abel L., and Casanova J.L. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 202 (2005) 1617-1621
13. MacLennan C., Fieschi C., Lammas D.A., Picard C., Dorman S.E., Sanal O., et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 190 (2004) 1755-1757
14. Roesler J., Kofink B., Wendisch J., Heyden S., Paul D., Friedrich W., et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol 27 (1999) 1368-1374
15. Picard C., Fieschi C., Altare F., Al-Jumaah S., Al-Hajjar S., Feinberg J., et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 70 (2002) 336-348
16. Dorman S.E., Uzel G., Roesler J., Bradley J.S., Bastian J., Billman G., et al. Viral infections in interferon-γ receptor deficiency. J Pediatr 135 (1999) 640-643
17. Camcioglu Y., Picard C., Lacoste V., Dupuis S., Akcakaya N., Cokura H., et al. HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr 144 (2004) 519-523
18. Zerbe C.S., and Holland S.M. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 41 (2005) e38-e41
19. Moraes-Vasconcelos D., Grumach A.S., Yamaguti A., Andrade M.E., Fieschi C., Beaucoudrey L., et al. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis 41 (2005) e31-e37
20. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335 (1996) 1941-1949
21. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 335 (1996) 1956-1961
22. Jouanguy E., Lamhamedi-Cherradi S., Lammas D., Dorman S.E., Fondaneche M.C., Dupuis S., et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 21 (1999) 370-378
23. Jouanguy E., Dupuis S., Pallier A., Döffinger R., Fondanèche M.C., Lamhamedi-Cherradi S., et al. In a novel form of complete IFNγR1 deficiency, cell-surface receptors fail to bind IFNγ. J Clin Invest 105 (2000) 1429-1436
24. Dorman S.E., and Holland S.M. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 101 (1998) 2364-2369
25. Rosenzweig S.D., Dorman S.E., Uzel G., Shaw S., Scurlock A., Brown M.R., et al. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 173 (2004) 4000-4008
26. Vogt G., Chapgier A., Yang K., Chuzhanova N., Feinberg J., Fieschi C., et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 37 (2005) 692-700
27. Döffinger R., Jouanguy E., Dupuis S., Fondanèche M.C., Stéphan J.L., Emile J.F., et al. Partial interferon gamma receptor signalling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis 181 (2000) 379-384
28. Altare F., Lammas D., Revy P., Jouanguy E., Doffinger R., Lamhamedi S., et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 102 (1998) 2035-2040
29. Altare F., Durandy A., Lammas D., Emile J.F., Lamhamedi S., Le Deist F., et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280 (1998) 1432-1435
30. de Jong R., Altare F., Haagen I.A., Elferink D.G., Boer T., van Breda Vriesman P.J., et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280 (1998) 1435-1438
31. Fieschi C., Bosticardo M., de Beaucoudrey L., Boisson-Dupuis S., Feinberg J., Santos O.F., et al. A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors. Blood 104 (2004) 2095-2101
32. Dupuis S., Dargemont C., Fieschi C., Thomassin N., Rosenzweig S., Harris J., et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293 (2001) 300-303
33. Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLos Genetic 2006;18:2(8).
34. Filipe-Santos O., Bustamante J., Haverkamp M.H., Vinolo E., Ku C.-L., Puel A., et al. X-linked susceptibility to mycobacteria is caused by mutations in the NEMO leucine zipper domain that impair CD40-dependent IL-12 production. J Exp Med 203 (2006) 1745-1759
35. Lichtenauer-Kaligis E.G., de Boer T., Verreck F.A., van Voorden S., Hoeve M.A., van de Vosse E., et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur J Immunol 33 (2003) 59-69
36. Dupuis S., Jouanguy E., Al-Hajjar S., Fieschi C., Al-Mohsen I.Z., Al-Jumaah S., et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33 (2003) 388-391
37. Chapgier A., Wynn R.F., Jouanguy E., Filipe-Santos O., Zhang S., Feinberg J., et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 176 (2006) 5078-5083
38. Novelli F., and Casanova J.L. The role of IL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev 15 (2004) 367-377
39. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27 (2001) 277-285
40. Jain A., Ma C.A., Liu S., Brown M., Cohen J., and Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2 (2001) 223-228
41. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 67 (2000) 1555-1562
42. Dorman S.E., Picard C., Lammas D., Heyne K., van Dissel J.T., Baretto R., et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 364 (2004) 2113-2121
43. Jouanguy E., Doffinger R., Dupuis S., Pallier A., Altare F., and Casanova J.L. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 11 (1999) 346-351
44. Fieschi C., and Casanova J.L. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur J Immunol 33 (2003) 1461-1464
45. Dupuis S., Doffinger R., Picard C., Fieschi C., Altare F., Jouanguy E., et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 178 (2000) 129-137
46. Casanova J.L., and Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4 (2004) 55-66
47. Casanova J.L., and Ochs H.D. Interferon γ receptor deficiency: an expanding phenotype?. J Pediatr 135 (1999) 543-545
48. Holland S.M. Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection. Microbes Infect 2 (2000) 1579-1590
49. Reichenbach J., Rosenzweig S., Doffinger R., Dupuis S., Holland S.M., and Casanova J.L. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 1 (2001) 503-511
50. Döffinger R., Jouanguy E., Altare F., Wood P., Shirakawa T., Novelli F., et al. Inheritable defects in IL-12- and IFNg-mediated immunity and the TH1/TH2 paradigm in man. Allergy 54 (1999) 409-412
51. Remus N., Reichenbach J., Picard C., Rietschel C., Wood P., Lammas D., et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res 50 (2001) 8-13
52. Rosenzweig S.D., and Holland S.M. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 203 (2005) 38-47
53. Ottenhoff T., Kumararatne D., and Casanova J.L. Novel immunodeficiencies reveal the essential role of type 1 cytokines in immunity to intracellular bacteria. Immunol Today 19 (1998) 491-494
54. van de Vosse E., Hoeve M.A., and Ottenhoff T.H. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4 (2004) 739-749
55. Notarangelo L., Casanova J.L., Conley M.E., Chapel H., Fischer A., Puck J., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest. J Allergy Clin Immunol 117 (2006) 883-896
56. Altare F., Jouanguy E., Lamhamedi S., Doffinger R., Fischer A., and Casanova J.L. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 10 (1998) 413-417
57. Ottenhoff T.H., Verreck F.A., Lichtenauer-Kaligis E.G., Hoeve M.A., Sanal O., and van Dissel J.T. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 32 (2002) 97-105
58. Haverkamp M.H., van Dissel J.T., and Holland S.M. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect 8 (2006) 1157-1166
59. Wood P.M., Fieschi C., Picard C., Ottenhoff T.H., Casanova J.L., and Kumararatne D.S. Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children. Eur J Pediatr 164 (2005) 741-747
60. Farrar M.A., and Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11 (1993) 571-611
61. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
62. Bach E., Aguet M., and Schreiber R.D. The interferon gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15 (1997) 563-591
63. North R.J., and Jung Y.J. Immunity to tuberculosis. Annu Rev Immunol 22 (2004) 599-623
64. Pierre-Audigier C., Jouanguy E., Lamhamedi S., Altare F., Rauzier J., Vincent V., et al. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis 24 (1997) 982-984
65. Altare F., Jouanguy E., Lamhamedi-Cherradi S., Fondaneche M.C., Fizame C., Ribierre F., et al. A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNγ in a compound heterozygous child. Am J Hum Genet 62 (1998) 723-726
66. Holland S.A., Dorman S.E., Kwon A., Pitha-Rowe I.F., Frucht D.M., Gerstberger S.M., et al. Abnormal regulation of interferon gamma, interleukin 12, and tumor necrosis factor alpha in interferon gamma receptor 1 deficiency. J Infect Dis 178 (1998) 1095-1104
67. Roesler J., Kofink B., Wendisch J., Heyden S., Paul D., Lehmann R., et al. Recurrent mycobacterial and listeria infections in a child with interferon γ receptor deficiency: mutational analysis and evaluation of therapeutic options. Exp Haematol 27 (1999) 1368-1374
68. Cunningham J.A., Kellner J.D., Bridge P.J., Trevenen C.L., McLeod D.R., and Davies H.D. Disseminated bacille Calmette-Guérin infection in an infant with a novel deletion in the interferon-gamma receptor gene. Int J Tuberc Lung Dis 4 (2000) 791-794
69. Allende L.M., Lopez-Goyanes A., Paz-Artal E., Corell A., Garcia-Perez M.A., Varela P., et al. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol 8 (2001) 133-137
70. Rosenzweig S., Dorman S.E., Roesler J., Zelasko M., and Holland S.M. A novel autosomal recessive mutation defines a second mutational hotspot in the interferon gamma receptor 1 (IFNGR1) chain. Clin Immunol 102 (2002) 25-27
71. Koscielniak E., de Boer T., Dupuis S., Naumann L., Casanova J.L., and Ottenhoff T.H. Disseminated Mycobacterium peregrinum infection in a child with complete interferon-gamma receptor-1 deficiency. Pediatr Infect Dis J 22 (2003) 378-380
72. Tsolia M.N., Chapgier A., Taprantzi P., Servitzoglou M., Tassios I., Spyridis N., et al. Disseminated nontuberculous mycobacterial infection in a child with interferon-gamma receptor 1 deficiency. Eur J Pediatr 167 (2006) 458-461
73. Marazzi MG, Chapgier A, Defilippi AC, Pistoia V, Plebani A, Dell'Acqua A, et al. Disseminated Mycobacterium scrofulaceum infection in a child with interferon receptor 1 deficiency. in preparation.
74. Feinberg J., Fieschi C., Doffinger R., Feinberg M., Leclerc T., Boisson-Dupuis S., et al. Bacillus Calmette Guérin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol 34 (2004) 3276-3284
75. Emile J.F., Patey N., Altare F., Lamhamedi S., Jouanguy E., Boman F., et al., Quillard J. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol 181 (1997) 25-30
76. Roesler J., Horwitz M.E., Picard C., Bordigoni P., Davies G., Koscielniak E., et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 145 (2004) 806-812
77. Reuter U., Roesler J., Thiede C., and Friedrich W. Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation. Blood 100 (2002) 4234-4235
78. Horwitz M.E., Uzel G., Linton G.F., Miller J.A., Brown M.R., Malech H.L., et al. Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency. Blood 102 (2003) 2692-2694
79. Chantrain C.F., Bruwier A., Brichard B., Largent V., Chapgier A., Feinberg J., et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant 38 (2006) 75-76
80. Fieschi C., Dupuis S., Picard C., Smith C.I., Holland S.M., and Casanova J.L. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 107 (2001) E48
81. Remiszewski P., Roszkowska-Sliz B., Winek J., Chapgier A., Feinberg J., Langfort R., et al. Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration 73 (2006) 375-378
82. Arend S.M., Janssen R., Gosen J.J., Waanders H., de Boer T., Ottenhoff T.H., et al. Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor. Neth J Med 59 (2001) 140-151
83. Villella A., Picard C., Jouanguy E., Dupuis S., Popko S., Abughali N., et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 107 (2001) E47
84. Sasaki Y., Nomura A., Kusuhara K., Takada H., Ahmed S., Obinata K., et al. Genetic basis of patients with bacille Calmette-Guérin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type. J Infect Dis 185 (2002) 706-709
85. Han J.Y., Rosenzweig S.D., Church J.A., Holland S.M., and Ross L.A. Variable presentation of disseminated nontuberculous mycobacterial infections in a family with an interferon-gamma receptor mutation. Clin Infect Dis 39 (2004) 868-870
86. Smyth A.E., Jackson P., Lammas D., Asghar M.S., Crockard A.D., Casanova J.L., et al. Differential response to interferon-gamma therapy in a family with dominant negative partial interferon-gamma receptor1 deficiency. Eur J Pediatr 165 (2006) 71-72
87. Lopez-Correa C., Dorschner M., Brems H., Lazaro C., Clementi M., Upadhyaya M., et al. Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 10 (2001) 1387-1392
88. Lebo R.V., Ikuta T., Milunsky J.M., and Milunsky A. Rett syndrome from quintuple and triple deletions within the MECP2 deletion hotspot region. Clin Genet 59 (2001) 406-417
89. Schneider K.U., Sabherwal N., Jantz K., Roth R., Muncke N., Blum W.F., et al. Identification of a major recombination hotspot in patients with short stature and SHOX deficiency. Am J Hum Genet 77 (2005) 89-96
90. Zinn A.R., Ramos P., and Ross J.L. A second recombination hotspot associated with SHOX deletions. Am J Hum Genet 78 (2006) 523-525
91. Renauld J.C. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 3 (2003) 667-676
92. Imada K., and Leonard W.J. The Jak-STAT pathway. Mol Immunol 37 (2000) 1-11
93. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5 (2005) 521-531
94. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133-146
95. Elloumi-Zghal H., Barbouche M.R., Chemli J., Bejaoui M., Harbi A., Snoussi N., et al. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille Calmette-Guérin infection. J Infect Dis 185 (2002) 1468-1475
96. Mansouri D., Adimi P., Mirsaeidi M., Mansouri N., Khalilzadeh S., Masjedi M.R., et al. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr 164 (2005) 753-757
97. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202 (2005) 761-769
98. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., and O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 202 (2004) 139-156
99. Aksu G., Tirpan C., Cavusoglu C., Soydan S., Altare F., Casanova J.L., et al. Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. Pediatr Infect Dis J 20 (2001) 551-553
100. Fieschi C., Dupuis S., Catherinot E., Feinberg J., Bustamante J., Breiman A., et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 197 (2003) 527-535
101. Sakai T., Matsuoka M., Aoki M., Nosaka K., and Mitsuya H. Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 97 (2001) 2688-2694
102. Staretz-Haham O., Melamed R., Lifshitz M., Porat N., Fieschi C., Casanova J.L., et al. Interleukin-12 receptor beta1 deficiency presenting as recurrent Salmonella infection. Clin Infect Dis 37 (2003) 137-140
103. Cleary A.M., Tu W., Enright A., Giffon T., Dewaal-Malefyt R., Gutierrez K., et al. Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency. J Immunol 170 (2003) 597-603
104. Hoeve M.A., de Boer T., Langenberg D.M., Sanal O., Verreck F.A., and Ottenhoff T.H. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency. Eur J Immunol 33 (2003) 3393-3397
105. Ozen M., Ceyhan M., Sanal O., Bayraktar M., and Mesci L. Recurrent Salmonella bacteremia in interleukin-12 receptor {beta}1 deficiency. J Trop Pediatr 52 (2006) 296-298
106. Tanir G., Dogu F., Tuygun N., Ikinciogullari A., Aytekin C., Aydemir C., et al. Complete deficiency of the IL-12 receptor beta1 chain: three unrelated Turkish children with unusual clinical features. Eur J Pediatr 165 (2006) 415-417
107. Sanal O., Turul T., De Boer T., Van de Vosse E., Yalcin I., Tezcan I., et al. Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections. J Clin Immunol 26 (2006) 1-6
108. Kutukculer N., Genel F., Aksu G., Karapinar B., Ozturk C., Cavusoglu C., et al. Cutaneous leukocytoclastic vasculitis in a child with interleukin-12 receptor beta-1 deficiency. J Pediatr 148 (2006) 407-409
109. Ulrichs T., Fieschi C., Nevicka E., Hahn H., Brezina M., Kaufmann S.H., et al. Variable outcome of experimental interferon-gamma therapy of disseminated bacillus Calmette-Guérin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children. Eur J Pediatr 164 (2005) 166-172
110. Yu H.R., Chen R.F., Hong K.C., Bong C.N., Lee W.I., Kuo H.C., et al. IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol 35 (2005) 3664-3672
111. Yu Z., Manickan E., and Rouse B.T. Role of interferon-g in immunity to herpes simplex virus. J Leucoc Biol 60 (1996) 528-532
112. Casanova J.L., and Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med 202 (2005) 197-201
113. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
114. Agou F., Ye F., Goffinont S., Courtois G., Yamaoka S., Israel A., et al. NEMO trimerizes through its coiled-coil C-terminal domain. J Biol Chem 277 (2002) 17464-17475
115. Agou F., Traincard F., Vinolo E., Courtois G., Yamaoka S., Israel A., et al. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J Biol Chem 279 (2004) 27861-27869
116. Huang G.J., Zhang Z.Q., and Jin D.Y. Stimulation of IKK-gamma oligomerization by the human T-cell leukemia virus oncoprotein Tax. FEBS Lett 531 (2002) 494-498
117. Smahi A., Courtois G., Vabres P., Yamaoka S., Heuertz S., Munnich A., et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405 (2000) 466-472
118. Ku C.L., Dupuis-Girod S., Dittrich A.M., Bustamante J., Santos O.F., Schulze I., et al. NEMO mutations in two unrelated boys with severe infections and conical teeth. Pediatrics 115 (2005) 615-619
119. Schmid J.M., Junge S.A., Hossle J.P., Schneider E.M., Roosnek E., Seger R.A., et al. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation. Pediatrics 117 (2006) e1049-e1056
120. Dupuis-Girod S., Corradini N., Hadj-Rabia S., Fournet J.C., Faivre L., Le Deist F., et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109 (2002) e97
121. Orange J.S., Levy O., Brodeur S.R., Krzewski K., Roy R.M., Niemela J.E., et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol 114 (2004) 650-656
122. Niehues T., Reichenbach J., Neubert J., Gudowius S., Puel A., Horneff G., et al. A NEMO-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 114 (2004) 1456-1462
123. Puel A., Reichenbach J., Bustamante J., Ku C.L., Feinberg J., Doffinger R., et al. The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation. Am J Hum Genet 78 (2006) 691-701
124. Smahi A., Courtois G., Rabia S.H., Doffinger R., Bodemer C., Munnich A., et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11 (2002) 2371-2375
125. Abinun M., Spickett G., Appleton A.L., Flood T., and Cant A.J. Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr 155 (1996) 146-147
126. Mansour S., Woffendin H., Mitton S., Jeffery I., Jakins T., Kenwrick S., et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 99 (2001) 172-177
127. Aradhya S., Courtois G., Rajkovic A., Lewis R., Levy M., Israel A., et al. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet 68 (2001) 765-771
128. Orange J.S., Brodeur S.R., Jain A., Bonilla F.A., Schneider L.C., Kretschmer R., et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 109 (2002) 1501-1509
129. Nishikomori R., Akutagawa H., Maruyama K., Nakata-Hizume M., Ohmori K., Mizuno K., et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood 103 (2004) 4565-4572
130. Ku CL, Picard C, Erdos M, Jeurissen A, Bustamante J, Puel A, et al. IRAK-4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2006; in press.
131. Jain A., Ma C.A., Lopez-Granados E., Means G., Brady W., Orange J.S., et al. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J Clin Invest 114 (2004) 1593-1602
132. Kosaki K., Shimasaki N., Fukushima H., Hara M., Ogata T., and Matsuo N. Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID). Am J Hum Genet 69 (2001) 664-666
133. Carrol E.D., Gennery A.R., Flood T.J., Spickett G.P., and Abinun M. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch Dis Child 88 (2003) 340-341
134. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., and Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol 113 (2004) 725-733
135. Orstavik K.H., Kristiansen M., Knudsen G.P., Storhaug K., Vege A., Eiklid K., et al. Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation. Am J Med Genet A 140 (2006) 31-39
136. Nedorost S.T., Elewski B., Tomford J.W., and Camisa C. Rosacea-like lesions due to familial Mycobacterium avium-intracellulare infection. Int J Dermatol 30 (1991) 491-497
137. Frucht D.M., and Holland S.M. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J Immunol 157 (1996) 411-416
138. Frucht D.M., Sandberg D.I., Brown M.R., Gerstberger S.M., and Holland S.M. IL-12-independent costimulation pathways for interferon-γ production in familial disseminated Mycobacterium avium complex infection. Clin Immunol 91 (1999) 234-241
139. Holland S.M., Eisenstein E.M., Kuhns D.B., Turner M.L., Fleisher T.A., Strober W., et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 330 (1994) 1348-1355
140. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299 (2003) 2076-2079
141. Yang K., Puel A., Zhang S., Eidenschenk C., Ku C.L., Casrouge A., et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 23 (2005) 465-478
142. Ferrari S., and Plebani A. Cross-talk between CD40 and CD40L: lessons from primary immune deficiencies. Curr Opin Allergy Clin Immunol 2 (2002) 489-494
143. Etzioni A., and Ochs H.D. The hyper IgM syndrome-an evolving story. Pediatr Res 56 (2004) 519-525
144. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., Resnick I., et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131 (1997) 47-54
145. Dubos R.J., and Dubos J. The white plague; tuberculosis, man and society. 1st ed. (1952), Little Brown, Boston
146. Picard C., Casanova J., and Abel L. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr Opin Immunol 18 (2006) 383-390
147. Ball E.V., Stenson P.D., Abeysinghe S.S., Krawczak M., Cooper D.N., and Chuzhanova N.A. Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 26 (2005) 205-213